Kalvista Pharmaceuticals, Inc.
Ticker: KALV
| Insider | Title |
|---|---|
| Albert Cha | Director |
| Benjamin L Palleiko | CHIEF EXECUTIVE OFFICER, Director |
| Bong Y Koh | 10% or greater ownership |
| Brian Jg Pereira | Director |
| Brian Piekos | Chief Financial Officer |
| Christopher Yea | CHIEF DEVELOPMENT OFFICER |
| Co-investment Holdings Iii, Llc Vhcp | 10% or greater ownership |
| Daniel B Soland | CHIEF OPERATING OFFICER |
| Edward P. Feener | CHIEF SCIENTIFIC OFFICER |
| Edward W Unkart | Director |
| Healthcare Capital Partners Eg, L.p. Venrock | 10% or greater ownership |
| Healthcare Capital Partners Iii, L.p. Venrock | 10% or greater ownership |
| Management Eg, Llc Vhcp | 10% or greater ownership |
| Management Iii, Llc Vhcp | 10% or greater ownership |
| Martin Edwards | Director |
| Michael David Smith | Senior VP, Development |
| Nancy Stuart | Director |
| Nimish P Shah | 10% or greater ownership |
| Patrick Treanor | Director |
| Paul K. Audhya | CHIEF MEDICAL OFFICER |
| Thomas Andrew Crockett | CEO, Director |
| William Fairey | Director |